Tilray Brands (TLRY) Interest Coverage Ratio Growth (1y) (2018 - 2026)
Tilray Brands (TLRY) Interest Coverage Ratio Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -58.34% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -14.91% |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 91.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 91.32% |
| Nov 30, 2025 | -25.63% |
| Aug 31, 2025 | 246.97% |
| May 31, 2025 | -10,519.31% |
| Feb 28, 2025 | -850.48% |
| Nov 30, 2024 | -2.60% |
| Aug 31, 2024 | -4.97% |
| May 31, 2024 | 84.24% |
| Feb 29, 2024 | 93.27% |
| Nov 30, 2023 | 35.25% |
| Aug 31, 2023 | 92.48% |
| May 31, 2023 | 85.78% |
| Feb 28, 2023 | -2,343.81% |
| Nov 30, 2022 | 11.64% |
| Aug 31, 2022 | -449.92% |
| May 31, 2022 | -521.59% |
| May 31, 2021 | -310.47% |
| May 31, 2020 | -197.76% |
| Mar 31, 2020 | -830.07% |
| Dec 31, 2019 | -14,559.74% |